Etsuko Yamamoto Hattori
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Etsuko Yamamoto Hattori has a total of 91 co-authors. Here are the top co-authors by number of shared publications:
- Yoshiki Arakawa
Department of Neurosurgery, Kyoto University Graduate School of Medicine, Kyoto, Japan
8 shared publications Yohei Mineharu
Department of Neurosurgery, Kyoto University Graduate School of Medicine, Kyoto
7 shared publicationsMasahiro Tanji
Department of Neurosurgery, Kyoto University Graduate School of Medicine, Kyoto
6 shared publications- Noritaka Sano
Department of Neurosurgery, Kyoto University Graduate School of Medicine, Kyoto
6 shared publications Yasuzumi Matsui
Department of Neurosurgery, Kyoto University Graduate School of Medicine, Kyoto, Japan
4 shared publications- Hiroshi Sugiyama
Department of Chemistry, Graduate School of Science, Kyoto University, Kitashirakawa-Oiwakecho, Sakyo-Ku, Kyoto 606-8502, Japan
3 shared publications
Latest Publications
- Open Access
- 6 July 2026
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery: Case Lessons
- Vol. 12 (1)
Prolonged isolated dysgeusia as an initial manifestation of neurolymphomatosis in primary central nervous system lymphoma: illustrative case
BACKGROUND: Neurolymphomatosis (NL) is an uncommon manifestation of lymphoma caused by direct nerve infiltration and often presents with nonspecific neurological symptoms, leading to delayed diagnosis. Isolated cranial nerve symptoms as an initial presentation are rare and may be overlooked. OBSERVATIONS: An 85-year-old woman presented with dysgeusia persisting for approximately 12 months, followed 2 months later by the development of diplopia, left peripheral facial nerve palsy, and left facial sensory disturbance. Contrast-enhanced MRI demonstrated enlargement and enhancement of the left trigeminal nerve, as well as enhancement of the facial and vestibulocochlear nerves within the internal auditory canal, along with an enhancing parenchymal lesion in the left frontal lobe. Biopsy of the frontal lobe lesion revealed diffuse large B-cell lymphoma, and bone marrow examination showed no systemic involvement, leading to the diagnosis of primary central nervous system lymphoma (PCNSL) with concurrent NL. Chemotherapy resulted in marked clinical improvement and resolution of imaging abnormalities. LESSONS: Isolated and subtle cranial nerve symptoms, such as dysgeusia, may precede overt neurological deficits in NL associated with PCNSL. Contrast-enhanced MRI should be considered early when the diagnosis remains unclear, as noncontrast imaging may fail to detect early cranial nerve involvement. https://thejns.org/doi/10.3171/CASE26296
- 6 July 2026
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery: Case Lessons
- Vol. 12 (1)
Open AccessProlonged isolated dysgeusia as an initial manifestation of neurolymphomatosis in primary central nervous system lymphoma: illustrative case
BACKGROUND: Neurolymphomatosis (NL) is an uncommon manifestation of lymphoma caused by direct nerve infiltration and often presents with nonspecific neurological symptoms, leading to delayed diagnosis. Isolated cranial nerve symptoms as an initial presentation are rare and may be overlooked. OBSERVATIONS: An 85-year-old woman presented with dysgeusia persisting for approximately 12 months, followed 2 months later by the development of diplopia, left peripheral facial nerve palsy, and left facial sensory disturbance. Contrast-enhanced MRI demonstrated enlargement and enhancement of the left trigeminal nerve, as well as enhancement of the facial and vestibulocochlear nerves within the internal auditory canal, along with an enhancing parenchymal lesion in the left frontal lobe. Biopsy of the frontal lobe lesion revealed diffuse large B-cell lymphoma, and bone marrow examination showed no systemic involvement, leading to the diagnosis of primary central nervous system lymphoma (PCNSL) with concurrent NL. Chemotherapy resulted in marked clinical improvement and resolution of imaging abnormalities. LESSONS: Isolated and subtle cranial nerve symptoms, such as dysgeusia, may precede overt neurological deficits in NL associated with PCNSL. Contrast-enhanced MRI should be considered early when the diagnosis remains unclear, as noncontrast imaging may fail to detect early cranial nerve involvement. https://thejns.org/doi/10.3171/CASE26296
- Open Access
- 25 May 2026
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery: Case Lessons
- Vol. 11 (21)
Navigation-guided endoscopic transcerebellar approach for cyst fenestration of a dorsal brainstem lesion: illustrative case
BACKGROUND: Surgical fenestration of dorsal brainstem cysts is commonly challenging to perform because of difficulties in selecting an optimal surgical corridor. Herein, the authors report a case of a dorsal brainstem cyst that was successfully treated with a navigation-guided endoscopic transcerebellar approach. OBSERVATIONS: A 9-year-old boy was diagnosed with optic pathway pilocytic astrocytoma at the age of 3 years. Subsequently, he required multiple procedures for tumor recurrence and growth of the cystic component. Despite these treatments, the dorsal brainstem cyst gradually enlarged, causing compression of the brainstem and fourth ventricle. A navigation-guided endoscopic transcerebellar approach for cyst fenestration was planned. The cyst wall was widely fenestrated via the suprafacial triangle on the floor of the fourth ventricle. Postoperatively, the patient developed transient truncal ataxia. However, he was discharged home after 2 weeks without neurological deficits. LESSONS: A navigation-guided endoscopic transcerebellar approach can be effective for dorsal brainstem cyst treatment. The surgical corridor is direct and linear, thereby allowing easy and reliable access. The entry point into the cyst should be located in the rostral portion of the floor of the fourth ventricle. Hence, it is important to create a sufficiently wide communication between the cyst and the fourth ventricle. https://thejns.org/doi/10.3171/CASE26161
- 25 May 2026
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery: Case Lessons
- Vol. 11 (21)
Open AccessNavigation-guided endoscopic transcerebellar approach for cyst fenestration of a dorsal brainstem lesion: illustrative case
BACKGROUND: Surgical fenestration of dorsal brainstem cysts is commonly challenging to perform because of difficulties in selecting an optimal surgical corridor. Herein, the authors report a case of a dorsal brainstem cyst that was successfully treated with a navigation-guided endoscopic transcerebellar approach. OBSERVATIONS: A 9-year-old boy was diagnosed with optic pathway pilocytic astrocytoma at the age of 3 years. Subsequently, he required multiple procedures for tumor recurrence and growth of the cystic component. Despite these treatments, the dorsal brainstem cyst gradually enlarged, causing compression of the brainstem and fourth ventricle. A navigation-guided endoscopic transcerebellar approach for cyst fenestration was planned. The cyst wall was widely fenestrated via the suprafacial triangle on the floor of the fourth ventricle. Postoperatively, the patient developed transient truncal ataxia. However, he was discharged home after 2 weeks without neurological deficits. LESSONS: A navigation-guided endoscopic transcerebellar approach can be effective for dorsal brainstem cyst treatment. The surgical corridor is direct and linear, thereby allowing easy and reliable access. The entry point into the cyst should be located in the rostral portion of the floor of the fourth ventricle. Hence, it is important to create a sufficiently wide communication between the cyst and the fourth ventricle. https://thejns.org/doi/10.3171/CASE26161
- Open Access
- 27 November 2025
- Published by Elsevier in World Neurosurgery
- Vol. 205, 124670
Usefulness of the Scalp Electroencephalography over Bone Defect for the Decoding of Muscle Activity
- 27 November 2025
- Published by Elsevier in World Neurosurgery
- Vol. 205, 124670
Open AccessUsefulness of the Scalp Electroencephalography over Bone Defect for the Decoding of Muscle Activity
- Open Access
- 6 October 2025
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery: Case Lessons
- Vol. 10 (14)
Successful management of recurrent multiple intracerebral TFE3-rearranged epithelioid hemangioendothelioma with repeated intervention and active surveillance: illustrative case
BACKGROUND: Epithelioid hemangioendothelioma (EHE) is a rare vascular tumor with intermediate malignant potential. TFE3 -rearranged intracerebral EHEs (iEHEs) have not been reported to date. Herein, the authors describe a rare case of recurrent multiple TFE3 -rearranged iEHEs involving the lung and liver, which exhibited a favorable clinical course after repeated surgeries, radiation therapy, and active surveillance. OBSERVATIONS: A 20-year-old man presented with multiple pulmonary, hepatic, and intracerebral lesions. The patient was diagnosed with EHE via biopsy of pulmonary lesions. During follow-up without treatment, progressive perilesional edema was observed in the left temporal lobe, leading to resection. Histological findings were consistent with EHE, and immunohistochemical analysis revealed overexpression of TFE3 in the tumor cells. Hence, a diagnosis of TFE3 -rearranged iEHE was established. Immediately after detecting progressive lesions, the patient received multiple interventions including surgery and radiation therapy. Radiological findings revealed multiple cystic lesions with hemorrhagic components. The tumor has been successfully controlled for 13 years with repeated surgeries, radiation therapy, and active surveillance. LESSONS: TFE3 -rearranged iEHE is an extremely rare type of tumor and can present with multiple cystic lesions containing hemorrhagic components on imaging. TFE3 -rearranged iEHE can be successfully managed with repeated intervention and active surveillance. https://thejns.org/doi/10.3171/CASE25416
- 6 October 2025
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery: Case Lessons
- Vol. 10 (14)
Open AccessSuccessful management of recurrent multiple intracerebral TFE3-rearranged epithelioid hemangioendothelioma with repeated intervention and active surveillance: illustrative case
BACKGROUND: Epithelioid hemangioendothelioma (EHE) is a rare vascular tumor with intermediate malignant potential. TFE3 -rearranged intracerebral EHEs (iEHEs) have not been reported to date. Herein, the authors describe a rare case of recurrent multiple TFE3 -rearranged iEHEs involving the lung and liver, which exhibited a favorable clinical course after repeated surgeries, radiation therapy, and active surveillance. OBSERVATIONS: A 20-year-old man presented with multiple pulmonary, hepatic, and intracerebral lesions. The patient was diagnosed with EHE via biopsy of pulmonary lesions. During follow-up without treatment, progressive perilesional edema was observed in the left temporal lobe, leading to resection. Histological findings were consistent with EHE, and immunohistochemical analysis revealed overexpression of TFE3 in the tumor cells. Hence, a diagnosis of TFE3 -rearranged iEHE was established. Immediately after detecting progressive lesions, the patient received multiple interventions including surgery and radiation therapy. Radiological findings revealed multiple cystic lesions with hemorrhagic components. The tumor has been successfully controlled for 13 years with repeated surgeries, radiation therapy, and active surveillance. LESSONS: TFE3 -rearranged iEHE is an extremely rare type of tumor and can present with multiple cystic lesions containing hemorrhagic components on imaging. TFE3 -rearranged iEHE can be successfully managed with repeated intervention and active surveillance. https://thejns.org/doi/10.3171/CASE25416
- 16 August 2025
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
- Vol. 46 (1) , 151-161
Abnormal perinidal cerebral metabolism is associated with symptoms in brain arteriovenous malformation: New insights by a novel approach using oxygen-15 labelled tracers and PET
The mechanisms underlying neurological symptoms, including epilepsy, in unruptured brain arteriovenous malformations (bAVM) remain to be elucidated. The dual-tracer basis function method (DBFM) with single-scan dual-tracer ( 15 O 2 and C 15 O 2 ) approach is a novel PET imaging technique that can evaluate the hemodynamics and metabolism of brain tissue adjacent to the nidus without the influence of abundant vascular radioactivity. We aimed to clarify the relationship between neurological symptoms and hemodynamic and metabolic abnormalities using the DBFM. Cerebral blood volume (CBV), cerebral blood flow (CBF), cerebral metabolic rate of oxygen (CMRO 2 ), and oxygen extraction fraction (OEF) were compared between symptomatic and asymptomatic bAVMs and before and after treatment. Among 46 patients with unruptured bAVMs who underwent DBFM, 26 cases were included. While CBV and OEF increased in the perinidus (p < 0.01), CBF and CMRO 2 decreased (p < 0.01). Symptoms were significantly associated with higher OEF (symptomatic vs. asymptomatic, ratio of perinidal to contralateral, n = 13 vs. n = 13, 1.07 ± 0.030 vs. 1.01 ± 0.080, p = 0.017). All elevated OEFs in symptomatic bAVMs with therapeutic symptom resolved in post-therapeutic PET imaging. DBFM revealed a higher OEF was associated with symptomatic bAVM. The DBFM potentially aids in predicting post-therapeutic symptom improvement.
- 16 August 2025
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
- Vol. 46 (1) , 151-161
Abnormal perinidal cerebral metabolism is associated with symptoms in brain arteriovenous malformation: New insights by a novel approach using oxygen-15 labelled tracers and PET
The mechanisms underlying neurological symptoms, including epilepsy, in unruptured brain arteriovenous malformations (bAVM) remain to be elucidated. The dual-tracer basis function method (DBFM) with single-scan dual-tracer ( 15 O 2 and C 15 O 2 ) approach is a novel PET imaging technique that can evaluate the hemodynamics and metabolism of brain tissue adjacent to the nidus without the influence of abundant vascular radioactivity. We aimed to clarify the relationship between neurological symptoms and hemodynamic and metabolic abnormalities using the DBFM. Cerebral blood volume (CBV), cerebral blood flow (CBF), cerebral metabolic rate of oxygen (CMRO 2 ), and oxygen extraction fraction (OEF) were compared between symptomatic and asymptomatic bAVMs and before and after treatment. Among 46 patients with unruptured bAVMs who underwent DBFM, 26 cases were included. While CBV and OEF increased in the perinidus (p < 0.01), CBF and CMRO 2 decreased (p < 0.01). Symptoms were significantly associated with higher OEF (symptomatic vs. asymptomatic, ratio of perinidal to contralateral, n = 13 vs. n = 13, 1.07 ± 0.030 vs. 1.01 ± 0.080, p = 0.017). All elevated OEFs in symptomatic bAVMs with therapeutic symptom resolved in post-therapeutic PET imaging. DBFM revealed a higher OEF was associated with symptomatic bAVM. The DBFM potentially aids in predicting post-therapeutic symptom improvement.
- Open Access
- 14 July 2025
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery: Case Lessons
- Vol. 10 (2)
Diffuse midline glioma H3K27-altered with thoracic epidural metastasis: illustrative case
BACKGROUND: Diffuse midline glioma (DMG) H3K27-altered is a newly recognized diffuse high-grade tumor entity in the 5th edition of the WHO classification of CNS tumors. Spinal extradural metastasis is extremely rare in patients with DMG H3K27-altered, while the occurrence of spinal intramedullary DMG, intradural dissemination, and osseous metastasis has been reported. OBSERVATIONS: The authors report the case of a 6-year-old female presenting with acute-onset urinary retention and paraplegia, who was found to have a pontine DMG, an intradural mass at the level of T1–6, and an extradural lesion at T6–9. The thecal sac was severely compressed by the extradural mass; thus, a T6–9 laminectomy and extradural tumor resection were performed. After the procedure, an amelioration of weakness was observed. The patient was treated with radiotherapy to the spine. Pathology revealed an increase in chromatin, the proliferation of atypical cells, and microvascular proliferation. The H3K27 mutation was confirmed. LESSONS: This case demonstrates an operative view in the metastasis of DMG H3K27-altered to the spinal epidural space without visceral or osseous metastasis. The possibility of spinal epidural metastasis and its surgical treatability should be considered if patients with DMG present spinal cord symptoms. https://thejns.org/doi/10.3171/CASE25249
- 14 July 2025
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery: Case Lessons
- Vol. 10 (2)
Open AccessDiffuse midline glioma H3K27-altered with thoracic epidural metastasis: illustrative case
BACKGROUND: Diffuse midline glioma (DMG) H3K27-altered is a newly recognized diffuse high-grade tumor entity in the 5th edition of the WHO classification of CNS tumors. Spinal extradural metastasis is extremely rare in patients with DMG H3K27-altered, while the occurrence of spinal intramedullary DMG, intradural dissemination, and osseous metastasis has been reported. OBSERVATIONS: The authors report the case of a 6-year-old female presenting with acute-onset urinary retention and paraplegia, who was found to have a pontine DMG, an intradural mass at the level of T1–6, and an extradural lesion at T6–9. The thecal sac was severely compressed by the extradural mass; thus, a T6–9 laminectomy and extradural tumor resection were performed. After the procedure, an amelioration of weakness was observed. The patient was treated with radiotherapy to the spine. Pathology revealed an increase in chromatin, the proliferation of atypical cells, and microvascular proliferation. The H3K27 mutation was confirmed. LESSONS: This case demonstrates an operative view in the metastasis of DMG H3K27-altered to the spinal epidural space without visceral or osseous metastasis. The possibility of spinal epidural metastasis and its surgical treatability should be considered if patients with DMG present spinal cord symptoms. https://thejns.org/doi/10.3171/CASE25249
- Open Access
- 14 July 2025
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery: Case Lessons
- Vol. 10 (2)
De novo aneurysm formation on choroidal anastomosis during pregnancy in moyamoya disease: illustrative case
BACKGROUND: Hemorrhagic stroke during pregnancy can cause devastating outcomes in women with moyamoya disease (MMD). The bleeding risk associated with choroidal anastomosis, a unique collateral manifestation of MMD, remains unknown in the context of pregnancy. OBSERVATIONS: A 29-year-old woman with asymptomatic MMD became pregnant. She had not undergone bypass surgery, and choroidal anastomosis had developed in the right hemisphere. After an uneventful pregnancy for 34 weeks, she suddenly manifested HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome and underwent an emergency cesarean section. Although both she and her neonate remained healthy, MR angiography after delivery revealed on the choroidal anastomosis a small aneurysm, which had been absent before conception, with the possible finding of minor bleeding. After recovering from HELLP syndrome, she underwent direct bypass surgery, which resulted in the disappearance of the aneurysm and marked reduction of the choroidal anastomosis. LESSONS: Choroidal anastomosis may carry a potential risk of aneurysm formation causing bleeding and should be carefully monitored with noninvasive imaging modalities during the antenatal and postpartum periods. https://thejns.org/doi/10.3171/CASE25112
- 14 July 2025
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery: Case Lessons
- Vol. 10 (2)
Open AccessDe novo aneurysm formation on choroidal anastomosis during pregnancy in moyamoya disease: illustrative case
BACKGROUND: Hemorrhagic stroke during pregnancy can cause devastating outcomes in women with moyamoya disease (MMD). The bleeding risk associated with choroidal anastomosis, a unique collateral manifestation of MMD, remains unknown in the context of pregnancy. OBSERVATIONS: A 29-year-old woman with asymptomatic MMD became pregnant. She had not undergone bypass surgery, and choroidal anastomosis had developed in the right hemisphere. After an uneventful pregnancy for 34 weeks, she suddenly manifested HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome and underwent an emergency cesarean section. Although both she and her neonate remained healthy, MR angiography after delivery revealed on the choroidal anastomosis a small aneurysm, which had been absent before conception, with the possible finding of minor bleeding. After recovering from HELLP syndrome, she underwent direct bypass surgery, which resulted in the disappearance of the aneurysm and marked reduction of the choroidal anastomosis. LESSONS: Choroidal anastomosis may carry a potential risk of aneurysm formation causing bleeding and should be carefully monitored with noninvasive imaging modalities during the antenatal and postpartum periods. https://thejns.org/doi/10.3171/CASE25112
- Open Access
- 21 April 2025
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery: Case Lessons
- Vol. 9 (16)
Chronic expanding hematoma following Gamma Knife irradiation for primary central nervous system lymphoma: illustrative case
BACKGROUND: Chronic expanding hematoma (CEH) is a rare disease characterized by slow expansion, especially reported after Gamma Knife radiosurgery (GKRS) for cerebral arteriovenous malformations. No cases have been reported following treatment for primary central nervous system lymphoma (PCNSL). Vascular endothelial growth factor and vascular endothelial growth factor receptor-1 (VEGFR-1) have been reported to be responsible for CEH induction. OBSERVATIONS: A 56-year-old woman underwent partial tumor removal for PCNSL in the left temporo-occipital lobe at another hospital. One and a half months later, a new lesion was observed, and she underwent GKRS, including the residual lesion. She was treated with multiple chemotherapy regimens including R-MPV (rituximab, methotrexate, procarbazine, vincristine) but relapsed repeatedly and was administered tirabrutinib. Four years after GKRS, the gadolinium-enhanced lesion slowly grew. Tumor recurrence or radiation necrosis was suspected, and surgical removal was performed. The tissue was composed of nonmalignant brain tissue and fibrinized hematoma, which demonstrated strong expression of VEGFR-1 on immunostaining, and the pathological diagnosis was CEH. LESSONS: In this patient, CEH could have resulted from VEGFR-1 expression due to GKRS. For a patient with slow lesion growth following GKRS for PCNSL, surgical removal should be considered, taking into account the possibility of CEH along with recurrence and radiation necrosis. https://thejns.org/doi/10.3171/CASE258
- 21 April 2025
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery: Case Lessons
- Vol. 9 (16)
Open AccessChronic expanding hematoma following Gamma Knife irradiation for primary central nervous system lymphoma: illustrative case
BACKGROUND: Chronic expanding hematoma (CEH) is a rare disease characterized by slow expansion, especially reported after Gamma Knife radiosurgery (GKRS) for cerebral arteriovenous malformations. No cases have been reported following treatment for primary central nervous system lymphoma (PCNSL). Vascular endothelial growth factor and vascular endothelial growth factor receptor-1 (VEGFR-1) have been reported to be responsible for CEH induction. OBSERVATIONS: A 56-year-old woman underwent partial tumor removal for PCNSL in the left temporo-occipital lobe at another hospital. One and a half months later, a new lesion was observed, and she underwent GKRS, including the residual lesion. She was treated with multiple chemotherapy regimens including R-MPV (rituximab, methotrexate, procarbazine, vincristine) but relapsed repeatedly and was administered tirabrutinib. Four years after GKRS, the gadolinium-enhanced lesion slowly grew. Tumor recurrence or radiation necrosis was suspected, and surgical removal was performed. The tissue was composed of nonmalignant brain tissue and fibrinized hematoma, which demonstrated strong expression of VEGFR-1 on immunostaining, and the pathological diagnosis was CEH. LESSONS: In this patient, CEH could have resulted from VEGFR-1 expression due to GKRS. For a patient with slow lesion growth following GKRS for PCNSL, surgical removal should be considered, taking into account the possibility of CEH along with recurrence and radiation necrosis. https://thejns.org/doi/10.3171/CASE258
- 17 April 2023
- Published by Elsevier in World Neurosurgery
- Vol. 175, e897-e903
Impact of Morphological Factors on the Future Growth of Unruptured Posterior Communicating Artery Aneurysms
- 17 April 2023
- Published by Elsevier in World Neurosurgery
- Vol. 175, e897-e903
Impact of Morphological Factors on the Future Growth of Unruptured Posterior Communicating Artery Aneurysms
- Open Access
- 26 January 2023
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 44 (2) , 143-149
Radiation-Induced Changes Associated with Obliteration of Brain AVMs after Repeat Radiosurgery
BACKGROUND AND PURPOSE: Radiation-induced changes can occur after stereotactic radiosurgery for brain AVMs, potentially causing symptomatic complications. We evaluated the incidence of such changes and the efficacy of repeat gamma knife radiosurgery for incompletely obliterated AVMs. MATERIALS AND METHODS: We retrospectively evaluated 150 patients who underwent gamma knife radiosurgery for AVMs between 2002 and 2020; twenty-five underwent further radiosurgical procedures for incompletely obliterated AVMs. We recorded the median margin doses at the first (median, 20 Gy; range, 12–23 Gy; AVM volume, 0.026–31.3 mL) and subsequent procedures (median, 18 Gy; range, 12–23 Gy; AVM volume, 0.048–9.2 mL). RESULTS: After the first treatment, radiologic radiation-induced changes developed in 48 (32%) patients, eight of whom had symptomatic changes. After repeat gamma knife radiosurgery, 16 of 25 patients achieved complete AVM obliteration (64%). The development of radiation-induced changes after the first treatment was significantly associated with successful obliteration by subsequent radiosurgery (OR = 24.0, 95% CI 1.20–483, P = .007). Radiation-induced changes occurred in only 5 (20%) patients who underwent a second gamma knife radiosurgery, one of whom experienced transient neurologic deficits. Between the first and repeat gamma knife radiosurgery procedures, there was no significant difference in radiologic and symptomatic radiation-induced changes (P = .35 and P = 1.0, respectively). CONCLUSIONS: Radiation-induced changes after the first gamma knife radiosurgery were associated with AVM obliteration after a repeat procedure. The risk of symptomatic radiation-induced changes did not increase with retreatment. When the first procedure fails to achieve complete AVM obliteration, a favorable outcome can be achieved by a repeat gamma knife radiosurgery, even if radiation-induced changes occur after the first treatment.
- 26 January 2023
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 44 (2) , 143-149
Open AccessRadiation-Induced Changes Associated with Obliteration of Brain AVMs after Repeat Radiosurgery
BACKGROUND AND PURPOSE: Radiation-induced changes can occur after stereotactic radiosurgery for brain AVMs, potentially causing symptomatic complications. We evaluated the incidence of such changes and the efficacy of repeat gamma knife radiosurgery for incompletely obliterated AVMs. MATERIALS AND METHODS: We retrospectively evaluated 150 patients who underwent gamma knife radiosurgery for AVMs between 2002 and 2020; twenty-five underwent further radiosurgical procedures for incompletely obliterated AVMs. We recorded the median margin doses at the first (median, 20 Gy; range, 12–23 Gy; AVM volume, 0.026–31.3 mL) and subsequent procedures (median, 18 Gy; range, 12–23 Gy; AVM volume, 0.048–9.2 mL). RESULTS: After the first treatment, radiologic radiation-induced changes developed in 48 (32%) patients, eight of whom had symptomatic changes. After repeat gamma knife radiosurgery, 16 of 25 patients achieved complete AVM obliteration (64%). The development of radiation-induced changes after the first treatment was significantly associated with successful obliteration by subsequent radiosurgery (OR = 24.0, 95% CI 1.20–483, P = .007). Radiation-induced changes occurred in only 5 (20%) patients who underwent a second gamma knife radiosurgery, one of whom experienced transient neurologic deficits. Between the first and repeat gamma knife radiosurgery procedures, there was no significant difference in radiologic and symptomatic radiation-induced changes (P = .35 and P = 1.0, respectively). CONCLUSIONS: Radiation-induced changes after the first gamma knife radiosurgery were associated with AVM obliteration after a repeat procedure. The risk of symptomatic radiation-induced changes did not increase with retreatment. When the first procedure fails to achieve complete AVM obliteration, a favorable outcome can be achieved by a repeat gamma knife radiosurgery, even if radiation-induced changes occur after the first treatment.